Skip to content
★ Sign in to follow
바스

바스칸바이오제약 Stock: price and insider trades · South Korea

No insider purchase over the last 90 days. The latest, by 민천기, was filed 01 Sept 2025.

바스칸바이오제약: what insiders have been doing

Every trade that managers of 바스칸바이오제약 disclose to DART (FSS) is tracked on this page. The company sits in the Health Care sector. 1 insider has disclosed 1 filing since 2 November 2025.

There is no open-market purchase to report; the filings show 1 sale by 1 insider. The totals do not cover 1 filing with an undisclosed amount.

Across the 2,655 companies tracked on its exchange, the median is 7 filings; at 1 filing, this issuer sits below that mark. Over the whole record (from 2022), the tally stands at 11 purchases and 8 sales.

Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification.

In the same sector, recent insider purchases at Dynavox Group AB and UCB also feature in our signals. Every figure here comes from the filings published by DART (FSS) and describes the past, not future prices; it is not investment advice.

Insider Decl.
19
Thresholds
n/a
Buy Volume
n/a
11 ops. · all time
Sell Volume
n/a
8 ops. · all time

Who traded when

BuySale
민천기1 buy
이법표1 sale

Since the insiders bought

  • Filed 25 Jul 2023 · 1202 days ago
    -20.6%
    Entry 6,790.00 · Close at T+365 5,390.00

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

Financial data

· cache

Last declaration on 30 March 2026
Declarations19 total
  • ▼
    Executives
    0DART
    25,946 sharesKRXDART:20260330001352
  • ▲
    사외이사Executives(filed)
    0DART
    13,000 sharesShareKRXDART:20250901000433
    Canonical exit: 30 Nov 2025 (T+90)
  • ▲
    사외이사Executives
    0DART
    ShareKRXDART:20230725000427
    Canonical exit: 22 Oct 2023 (T+90)
  • ▼
    Executives
    0DART
    36,515 sharesKRXDART:20230725000419
  • ▼
    Executives
    0DART
    36,515 sharesKRXDART:20230725000188
  • ▲
    사외이사Executives
    0DART
    ShareKRXDART:20230725000202
    Canonical exit: 22 Oct 2023 (T+90)
  • ▲
    사외이사Executives(filed)
    0DART
    ShareKRXDART:20220727000014
    Canonical exit: 25 Oct 2022 (T+90)
  • ▼
    Executives(filed)
    0DART
    36,515 sharesKRXDART:20220727000213
  • ▼
    Executives(filed)
    0DART
    36,515 sharesKRXDART:20220727000308
  • ▼
    Executives(filed)
    0DART
    36,515 sharesKRXDART:20220727000128
  • ▲
    사외이사Executives(filed)
    0DART
    ShareKRXDART:20220726000040
    Canonical exit: 24 Oct 2022 (T+90)
  • ▲
    사외이사Executives(filed)
    0DART
    ShareKRXDART:20220726000054
    Canonical exit: 24 Oct 2022 (T+90)
  • ▼
    Executives(filed)
    0DART
    36,515 sharesKRXDART:20220725000270
  • ▲
    사외이사Executives(filed)
    0DART
    ShareKRXDART:20220725000298
    Canonical exit: 23 Oct 2022 (T+90)
  • ▲
    사외이사Executives(filed)
    0DART
    ShareKRXDART:20220725000108
    Canonical exit: 23 Oct 2022 (T+90)
  • ▲
    사외이사Executives(filed)
    0DART
    ShareKRXDART:20220725000185
    Canonical exit: 23 Oct 2022 (T+90)
  • ▲
    사외이사Executives(filed)
    0DART
    ShareKRXDART:20220725000113
    Canonical exit: 23 Oct 2022 (T+90)
  • ▲
    사외이사Executives(filed)
    0DART
    ShareKRXDART:20220725000070
    Canonical exit: 23 Oct 2022 (T+90)
  • ▼
    Executives(filed)
    0DART
    36,515 sharesKRXDART:20220720000274

19 of 19 declarations

About 바스칸바이오제약

Baskan Biopharmaceutical is a biopharmaceutical company focused on developing innovative treatments. It is listed on the XKRX market.

Recent ranked signals in the same sector

Purchases our model currently ranks for the recommendations list.

All recommendations